Image Ben Hargreaves Digital Paywalls threaten healthcare professional engagement on soci... The recent announcement that Elon Musk is considering introducing a paywall to X caused much discussion over the future of the platform. Sales & Marketing The rise and fall of the pandemic overachievers Ben Hargreaves examines how Pfizer, BioNTech, and Moderna are preparing for a future without COVID-19 revenue Digital Pharma dips toe into tech adoption, but is it deep enough? Ben Hargreaves looks at the uptake of enabling technology by the pharma industry. Market Access Medical drone delivery set for global take off Delivery by drone is often talked about in the retail sector – to make delivery of consumer goods quicker and with greater convenience. Load more results
Digital Paywalls threaten healthcare professional engagement on soci... The recent announcement that Elon Musk is considering introducing a paywall to X caused much discussion over the future of the platform.
Sales & Marketing The rise and fall of the pandemic overachievers Ben Hargreaves examines how Pfizer, BioNTech, and Moderna are preparing for a future without COVID-19 revenue
Digital Pharma dips toe into tech adoption, but is it deep enough? Ben Hargreaves looks at the uptake of enabling technology by the pharma industry.
Market Access Medical drone delivery set for global take off Delivery by drone is often talked about in the retail sector – to make delivery of consumer goods quicker and with greater convenience.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
